Avaliação da argila atapulgita para potencial uso como excipiente farmacêutico em formas sólidas

Detalhes bibliográficos
Autor(a) principal: Soares, Daiane dos Santos
Data de Publicação: 2013
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da UFRN
Texto Completo: https://repositorio.ufrn.br/jspui/handle/123456789/13492
Resumo: Clays are natural materials that have great potential for use as excipients for solid dosage forms. Palygorskite is a type of clay that has hydrophilic properties as well as a large surface area, which could contribute to the dissolution of drugs. Thus, the present study aims to evaluate the use of palygorskite clay, from Piaui (Northeast region of Brazil), as a pharmaceutical excipient for solid dosage forms, using rifampicin and isoniazid as the model drugs. The former is a poorly soluble drug often associated with isoniazid for tuberculosis treatment. Palygorskite was characterized by X-ray diffraction (XRD), X-ray fluorescence (XRF), particle size, transmission electron microscopy (TEM), scanning electron microscopy (SEM) and specific surface area (BET). The rheological and technological properties of palygorskite were determined and compared to those of talc, magnesium stearate and Aersosil 200. Mixtures between drugs and palygorskite were analyzed by differential scanning calorimetry (DSC), thermogravimetric analysis (TG) combined with thermal analysis (DTA) and Fourier Transform Infrared Spectroscopy (FT-IR), where the results were compared with those of the individual compounds. In addition, dissolution studies of solid dispersions and capsules containing the drugs, mixed with either palygorskite or a mixture of talc and magnesium stearate, were performed. The results showed that palygorskite has small particles with a high surface area. Its rheological characteristics were better than those of others commonly used glidants and lubricants. There was no interaction between palygorskite and the drugs (rifampicin and isoniazid). Among the dispersions studied, the mixture with palygorskite (5%) showed the highest drug dissolution when compared to other excipients. The dissolution of the rifampicin capsules containing palygosrkite was faster in higher concentrations. However, these differences were statistically different only in the first minutes of the dissolution experiment. The dissolution profile of isoniazid was also statistically different on the initial part of the experiment. The formulations prepared with isoniazid and palygorskite showed higher drug dissolution, but it was in descending order of concentration. According to these results, the palygorskite clay used in this study has great potential for application as an excipient for solid dosage forms
id UFRN_74031c0821ccb4a01d8bc520db3723dd
oai_identifier_str oai:https://repositorio.ufrn.br:123456789/13492
network_acronym_str UFRN
network_name_str Repositório Institucional da UFRN
repository_id_str
spelling Soares, Daiane dos Santoshttp://lattes.cnpq.br/4732149898233623http://lattes.cnpq.br/4452581275123481Silva Júnior, Arnóbio Antôniohttp://lattes.cnpq.br/2593509584288129Moura, Túlio Flávio Accioly Lima e2014-12-17T14:16:34Z2013-10-162014-12-17T14:16:34Z2013-05-22SOARES, Daiane dos Santos. Avaliação da argila atapulgita para potencial uso como excipiente farmacêutico em formas sólidas. 2013. 93 f. Dissertação (Mestrado em Bioanálises e Medicamentos) - Universidade Federal do Rio Grande do Norte, Natal, 2013.https://repositorio.ufrn.br/jspui/handle/123456789/13492Clays are natural materials that have great potential for use as excipients for solid dosage forms. Palygorskite is a type of clay that has hydrophilic properties as well as a large surface area, which could contribute to the dissolution of drugs. Thus, the present study aims to evaluate the use of palygorskite clay, from Piaui (Northeast region of Brazil), as a pharmaceutical excipient for solid dosage forms, using rifampicin and isoniazid as the model drugs. The former is a poorly soluble drug often associated with isoniazid for tuberculosis treatment. Palygorskite was characterized by X-ray diffraction (XRD), X-ray fluorescence (XRF), particle size, transmission electron microscopy (TEM), scanning electron microscopy (SEM) and specific surface area (BET). The rheological and technological properties of palygorskite were determined and compared to those of talc, magnesium stearate and Aersosil 200. Mixtures between drugs and palygorskite were analyzed by differential scanning calorimetry (DSC), thermogravimetric analysis (TG) combined with thermal analysis (DTA) and Fourier Transform Infrared Spectroscopy (FT-IR), where the results were compared with those of the individual compounds. In addition, dissolution studies of solid dispersions and capsules containing the drugs, mixed with either palygorskite or a mixture of talc and magnesium stearate, were performed. The results showed that palygorskite has small particles with a high surface area. Its rheological characteristics were better than those of others commonly used glidants and lubricants. There was no interaction between palygorskite and the drugs (rifampicin and isoniazid). Among the dispersions studied, the mixture with palygorskite (5%) showed the highest drug dissolution when compared to other excipients. The dissolution of the rifampicin capsules containing palygosrkite was faster in higher concentrations. However, these differences were statistically different only in the first minutes of the dissolution experiment. The dissolution profile of isoniazid was also statistically different on the initial part of the experiment. The formulations prepared with isoniazid and palygorskite showed higher drug dissolution, but it was in descending order of concentration. According to these results, the palygorskite clay used in this study has great potential for application as an excipient for solid dosage formsArgilas são materiais naturais, com baixa toxicidade e com potencial para atuar como excipiente. A atapulgita é uma argila com característica hidrofílica e grande área superficial. Assim, este trabalho tem por objetivo avaliar o uso da atapulgita como excipiente farmacêutico em formas sólidas, utilizando a rifampicina e a isoniazida como fármacos-modelo. A atapulgita é proveniente do Estado do Piauí, Nordeste, Brasil. A rifampicina é um fármaco de baixa solubilidade frequentemente associado à isoniazida para o tratamento da tuberculose. Inicialmente a atapulgita foi caracterizada por difração de raios-X (DRX), fluorescência de raios-X (FRX), análise granulométrica, microscopia eletrônica de transmissão (MET) e varredura (MEV) e determinação da área de superfície específica (BET). As propriedades reológicas e tecnológicas da argila foram determinadas e comparadas ao talco, estearato de magnésio e Aerosil 200. Misturas entre os fármacos e a argila (1:1, 1:2 e 1:1:1), bem como os materiais isolados, foram avaliadas por calorimetria exploratória diferencial (DSC), análise termogravimétrica (TG) combinada à análise térmica diferencial (DTA) e espectroscopia na região do infravermelho com transformada de Fourier (FT- IR). Estudos de dissolução de dispersões sólidas e de cápsulas contendo os fármacos e a atapulgita foram realizados e comparados ao emprego de talco e estearato de magnésio. Os resultados mostraram que a atapulgita apresenta partículas pequenas, com grande área de superfície. Apresentou boas características reológicas quando comparada ao demais reguladores de fluxo. Não foi evidenciada interação com os fármacos testados. Entre as dispersões, as misturas com atapulgita (5%) mostraram maior dissolução dos fármacos em relação a outros excipientes . O perfil de dissolução da rifampicina foi superior na formulação de cápsula contendo atapulgita em maior concentração, sendo estatisticamente diferente nos primeiros minutos. O perfil de dissolução da isoniazida também se mostrou estatisticamente diferente nos primeiros minutos, sendo as formulações com atapulgita as que apresentaram maior dissolução do fármaco, porém em ordem decrescente de concentração. A argila atapulgita apresenta, portanto, potencial para aplicação como excipiente em formas farmacêuticas sólidasapplication/pdfporUniversidade Federal do Rio Grande do NortePrograma de Pós-Graduação em Ciências FarmacêuticasUFRNBRBioanálises e MedicamentosAtapulgita. Rifampicina. Isoniazida. Dissolução. Compatibilidade. CaracterizaçãoCNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIAAvaliação da argila atapulgita para potencial uso como excipiente farmacêutico em formas sólidasinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFRNinstname:Universidade Federal do Rio Grande do Norte (UFRN)instacron:UFRNORIGINALAvaliacaoArgilaAtapulgita_Soares_2013.pdfapplication/pdf2054024https://repositorio.ufrn.br/bitstream/123456789/13492/1/AvaliacaoArgilaAtapulgita_Soares_2013.pdfbee46a4b535270b61e0c79e3911040aaMD51TEXTDaianeSS_DISSERT.pdf.txtDaianeSS_DISSERT.pdf.txtExtracted texttext/plain141376https://repositorio.ufrn.br/bitstream/123456789/13492/6/DaianeSS_DISSERT.pdf.txt8708bd0d930155f8404b5450b426de76MD56AvaliacaoArgilaAtapulgita_Soares_2013.pdf.txtAvaliacaoArgilaAtapulgita_Soares_2013.pdf.txtExtracted texttext/plain141287https://repositorio.ufrn.br/bitstream/123456789/13492/8/AvaliacaoArgilaAtapulgita_Soares_2013.pdf.txtf294eaa596d654eee4f0fc27dfa1d06dMD58THUMBNAILDaianeSS_DISSERT.pdf.jpgDaianeSS_DISSERT.pdf.jpgIM Thumbnailimage/jpeg3152https://repositorio.ufrn.br/bitstream/123456789/13492/7/DaianeSS_DISSERT.pdf.jpg981f01f6df3335022002ca39c4edfb6cMD57AvaliacaoArgilaAtapulgita_Soares_2013.pdf.jpgAvaliacaoArgilaAtapulgita_Soares_2013.pdf.jpgGenerated Thumbnailimage/jpeg1274https://repositorio.ufrn.br/bitstream/123456789/13492/9/AvaliacaoArgilaAtapulgita_Soares_2013.pdf.jpgc9aef60c587067279cca92c9bb6ae83fMD59123456789/134922019-05-26 02:23:05.817oai:https://repositorio.ufrn.br:123456789/13492Repositório de PublicaçõesPUBhttp://repositorio.ufrn.br/oai/opendoar:2019-05-26T05:23:05Repositório Institucional da UFRN - Universidade Federal do Rio Grande do Norte (UFRN)false
dc.title.por.fl_str_mv Avaliação da argila atapulgita para potencial uso como excipiente farmacêutico em formas sólidas
title Avaliação da argila atapulgita para potencial uso como excipiente farmacêutico em formas sólidas
spellingShingle Avaliação da argila atapulgita para potencial uso como excipiente farmacêutico em formas sólidas
Soares, Daiane dos Santos
Atapulgita. Rifampicina. Isoniazida. Dissolução. Compatibilidade. Caracterização
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
title_short Avaliação da argila atapulgita para potencial uso como excipiente farmacêutico em formas sólidas
title_full Avaliação da argila atapulgita para potencial uso como excipiente farmacêutico em formas sólidas
title_fullStr Avaliação da argila atapulgita para potencial uso como excipiente farmacêutico em formas sólidas
title_full_unstemmed Avaliação da argila atapulgita para potencial uso como excipiente farmacêutico em formas sólidas
title_sort Avaliação da argila atapulgita para potencial uso como excipiente farmacêutico em formas sólidas
author Soares, Daiane dos Santos
author_facet Soares, Daiane dos Santos
author_role author
dc.contributor.authorID.por.fl_str_mv
dc.contributor.authorLattes.por.fl_str_mv http://lattes.cnpq.br/4732149898233623
dc.contributor.advisorID.por.fl_str_mv
dc.contributor.advisorLattes.por.fl_str_mv http://lattes.cnpq.br/4452581275123481
dc.contributor.referees1.pt_BR.fl_str_mv Silva Júnior, Arnóbio Antônio
dc.contributor.referees1ID.por.fl_str_mv
dc.contributor.referees1Lattes.por.fl_str_mv http://lattes.cnpq.br/2593509584288129
dc.contributor.author.fl_str_mv Soares, Daiane dos Santos
dc.contributor.advisor1.fl_str_mv Moura, Túlio Flávio Accioly Lima e
contributor_str_mv Moura, Túlio Flávio Accioly Lima e
dc.subject.por.fl_str_mv Atapulgita. Rifampicina. Isoniazida. Dissolução. Compatibilidade. Caracterização
topic Atapulgita. Rifampicina. Isoniazida. Dissolução. Compatibilidade. Caracterização
CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
dc.subject.cnpq.fl_str_mv CNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA
description Clays are natural materials that have great potential for use as excipients for solid dosage forms. Palygorskite is a type of clay that has hydrophilic properties as well as a large surface area, which could contribute to the dissolution of drugs. Thus, the present study aims to evaluate the use of palygorskite clay, from Piaui (Northeast region of Brazil), as a pharmaceutical excipient for solid dosage forms, using rifampicin and isoniazid as the model drugs. The former is a poorly soluble drug often associated with isoniazid for tuberculosis treatment. Palygorskite was characterized by X-ray diffraction (XRD), X-ray fluorescence (XRF), particle size, transmission electron microscopy (TEM), scanning electron microscopy (SEM) and specific surface area (BET). The rheological and technological properties of palygorskite were determined and compared to those of talc, magnesium stearate and Aersosil 200. Mixtures between drugs and palygorskite were analyzed by differential scanning calorimetry (DSC), thermogravimetric analysis (TG) combined with thermal analysis (DTA) and Fourier Transform Infrared Spectroscopy (FT-IR), where the results were compared with those of the individual compounds. In addition, dissolution studies of solid dispersions and capsules containing the drugs, mixed with either palygorskite or a mixture of talc and magnesium stearate, were performed. The results showed that palygorskite has small particles with a high surface area. Its rheological characteristics were better than those of others commonly used glidants and lubricants. There was no interaction between palygorskite and the drugs (rifampicin and isoniazid). Among the dispersions studied, the mixture with palygorskite (5%) showed the highest drug dissolution when compared to other excipients. The dissolution of the rifampicin capsules containing palygosrkite was faster in higher concentrations. However, these differences were statistically different only in the first minutes of the dissolution experiment. The dissolution profile of isoniazid was also statistically different on the initial part of the experiment. The formulations prepared with isoniazid and palygorskite showed higher drug dissolution, but it was in descending order of concentration. According to these results, the palygorskite clay used in this study has great potential for application as an excipient for solid dosage forms
publishDate 2013
dc.date.available.fl_str_mv 2013-10-16
2014-12-17T14:16:34Z
dc.date.issued.fl_str_mv 2013-05-22
dc.date.accessioned.fl_str_mv 2014-12-17T14:16:34Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv SOARES, Daiane dos Santos. Avaliação da argila atapulgita para potencial uso como excipiente farmacêutico em formas sólidas. 2013. 93 f. Dissertação (Mestrado em Bioanálises e Medicamentos) - Universidade Federal do Rio Grande do Norte, Natal, 2013.
dc.identifier.uri.fl_str_mv https://repositorio.ufrn.br/jspui/handle/123456789/13492
identifier_str_mv SOARES, Daiane dos Santos. Avaliação da argila atapulgita para potencial uso como excipiente farmacêutico em formas sólidas. 2013. 93 f. Dissertação (Mestrado em Bioanálises e Medicamentos) - Universidade Federal do Rio Grande do Norte, Natal, 2013.
url https://repositorio.ufrn.br/jspui/handle/123456789/13492
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal do Rio Grande do Norte
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Ciências Farmacêuticas
dc.publisher.initials.fl_str_mv UFRN
dc.publisher.country.fl_str_mv BR
dc.publisher.department.fl_str_mv Bioanálises e Medicamentos
publisher.none.fl_str_mv Universidade Federal do Rio Grande do Norte
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFRN
instname:Universidade Federal do Rio Grande do Norte (UFRN)
instacron:UFRN
instname_str Universidade Federal do Rio Grande do Norte (UFRN)
instacron_str UFRN
institution UFRN
reponame_str Repositório Institucional da UFRN
collection Repositório Institucional da UFRN
bitstream.url.fl_str_mv https://repositorio.ufrn.br/bitstream/123456789/13492/1/AvaliacaoArgilaAtapulgita_Soares_2013.pdf
https://repositorio.ufrn.br/bitstream/123456789/13492/6/DaianeSS_DISSERT.pdf.txt
https://repositorio.ufrn.br/bitstream/123456789/13492/8/AvaliacaoArgilaAtapulgita_Soares_2013.pdf.txt
https://repositorio.ufrn.br/bitstream/123456789/13492/7/DaianeSS_DISSERT.pdf.jpg
https://repositorio.ufrn.br/bitstream/123456789/13492/9/AvaliacaoArgilaAtapulgita_Soares_2013.pdf.jpg
bitstream.checksum.fl_str_mv bee46a4b535270b61e0c79e3911040aa
8708bd0d930155f8404b5450b426de76
f294eaa596d654eee4f0fc27dfa1d06d
981f01f6df3335022002ca39c4edfb6c
c9aef60c587067279cca92c9bb6ae83f
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFRN - Universidade Federal do Rio Grande do Norte (UFRN)
repository.mail.fl_str_mv
_version_ 1814832628961902592